(A) Axial and (B) coronal reformatted images from CT performed with IV contrast material show segmental visualization of main pancreatic duct (arrow). One of three reviewers described main duct dilation as present. Agreement among reviewers on CT for main duct dilatation was substantial (κ=0.63).

March 9, 2022 — According to an open-access Editor’s Choice article in ARRS’ American Journal of Roentgenology (AJR), interobserver agreement proved generally fair to moderate for most CT and MRI findings of chronic pancreatitis in children.

“This study highlights challenges for the imaging diagnosis of pediatric chronic pancreatitis,” wrote first author Andrew T. Trout of Cincinnati Children's Hospital Medical Center in Ohio. “Standardized and/or objective criteria are needed, given the importance of imaging in diagnosis.”

In Trout et al.’s retrospective study, CT or MRI examinations performed in children with chronic pancreatitis were submitted by six sites participating in the INternational Study Group of Pediatric Pancreatitis: In search for a cuRE (INSPPIRE) consortium. One board-certified pediatric radiologist from each of the six sites participated in independent image review. Three radiologists independently reviewed only CT examinations, whereas three other radiologists independently reviewed just MRI examinations. While measuring pancreas thickness and duct diameter, reviewers evaluated 13 categorical subjective features: 12 on both CT and MRI, 1 on CT only, 1 on MRI only.

In this study of six sites in the INSPPIRE consortium, interobserver agreement for findings of chronic pancreatitis in children was relatively high for CT for the presence of parenchymal calcifications (κ=0.81), pancreatic duct dilation (κ=0.63), and atrophy (κ=0.52); and for MRI for main and side branch pancreatic duct findings (κ=0.64-0.74).

Noting that duct findings showed the highest levels of agreement for both modalities, “agreement for subjective findings of atrophy was moderate, and agreement for parenchymal thickness (a quantitative measure of atrophy) depended on the location of measurement, with the best agreement observed in the pancreatic body,” the authors of this AJR article concluded.

For more information: www.arrs.org


Related Content

News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Radiology Business

March 12, 2026 — DelveInsight's has released its latest Diagnostic Imaging Equipment Market Insights report. The in ...

Time March 13, 2026
arrow
News | Enterprise Imaging

Mar. 9, 2026 — GE HealthCare recently announced that View, the viewer within the Genesis Radiology Workspace, has ...

Time March 12, 2026
arrow
News | Lung Imaging

March 11, 2026 — Noah Medical has announced the publication of the MATCH 2 study in the international, peer-reviewed ...

Time March 12, 2026
arrow
News | Computed Tomography (CT)

March 5, 2026 — At ECR 2026, Royal Philips introduced Rembra, its next-generation radiology CT system designed for the ...

Time March 09, 2026
arrow
News | FDA

Mar. 9, 2026 — GE HealthCare's View, the powerful viewer within the Genesis Radiology Workspace, has received 510(k) ...

Time March 09, 2026
arrow
Feature | Artificial Intelligence | Kyle Hardner

Once considered an adjunct brain cancer therapy and a last-resort treatment, noninvasive radiosurgery has evolved ...

Time March 09, 2026
arrow
News | HIMSS

March 5, 2026 — At the Health Information and Management Systems Society (HIMSS) Conference & Exhibition 2026 in Las ...

Time March 06, 2026
arrow
News | Radiology Business

March 5, 2026 — Cassling is now accepting applications for the 2026 Imaging for Impact Award, a national recognition ...

Time March 05, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
Subscribe Now